Login
Search
Search
0 Dates
2026
2025
2024
2023
2022
2021
2020
2019
2018
0 Events
CPC 2018
CPC 2019
Curso de Atualização em Medicina Cardiovascular 2019
Reunião Anual Conjunta dos Grupos de Estudo de Cirurgia Cardíaca, Doenças Valvulares e Ecocardiografia da SPC
CPC 2020
CPC 2021
CPC 2022
CPC 2023
CPC 2024
CPC 2025
CPC 2026
0 Topics
A. Basics
B. Imaging
C. Arrhythmias and Device Therapy
D. Heart Failure
E. Coronary Artery Disease, Acute Coronary Syndromes, Acute Cardiac Care
F. Valvular, Myocardial, Pericardial, Pulmonary, Congenital Heart Disease
G. Aortic Disease, Peripheral Vascular Disease, Stroke
H. Interventional Cardiology and Cardiovascular Surgery
I. Hypertension
J. Preventive Cardiology
K. Cardiovascular Disease In Special Populations
L. Cardiovascular Pharmacology
M. Cardiovascular Nursing
N. E-Cardiology / Digital Health, Public Health, Health Economics, Research Methodology
O. Basic Science
P. Other
0 Themes
01. History of Cardiology
02. Clinical Skills
03. Imaging
04. Arrhythmias, General
05. Atrial Fibrillation
06. Supraventricular Tachycardia (non-AF)
07. Syncope and Bradycardia
08. Ventricular Arrhythmias and Sudden Cardiac Death (SCD)
09. Device Therapy
10. Chronic Heart Failure
11. Acute Heart Failure
12. Coronary Artery Disease (Chronic)
13. Acute Coronary Syndromes
14. Acute Cardiac Care
15. Valvular Heart Disease
16. Infective Endocarditis
17. Myocardial Disease
18. Pericardial Disease
19. Tumors of the Heart
20. Congenital Heart Disease and Pediatric Cardiology
21. Pulmonary Circulation, Pulmonary Embolism, Right Heart Failure
22. Aortic Disease
23. Peripheral Vascular and Cerebrovascular Disease
24. Stroke
25. Interventional Cardiology
26. Cardiovascular Surgery
27. Hypertension
28. Risk Factors and Prevention
29. Rehabilitation and Sports Cardiology
30. Cardiovascular Disease in Special Populations
31. Pharmacology and Pharmacotherapy
32. Cardiovascular Nursing
33. e-Cardiology / Digital Health
34. Public Health and Health Economics
35. Research Methodology
36. Basic Science
37. Miscellanea
0 Resources
Abstract
Slides
Vídeo
Report
CLEAR FILTERS
Bridging the gap to definitive aortic valve treatment: outcomes after balloon aortic valvuloplasty
Session:
Sessão de Posters 04 - Prognóstico e desfechos clínicos na estenose aórtica
Speaker:
Tiago Filipe Aguiar
Congress:
CPC 2026
Topic:
F. Valvular, Myocardial, Pericardial, Pulmonary, Congenital Heart Disease
Theme:
15. Valvular Heart Disease
Subtheme:
15.4 Valvular Heart Disease – Treatment
Session Type:
Posters Eletrónicos
FP Number:
---
Authors:
Tiago Filipe Aguiar; David Couto; Mariana Santos; Diana Ribeiro; Pedro Monteiro; Tiago Peixoto; Joana Ribeiro; Gilles Sousa; Raquel Santos; Bruno Brochado; João Silveira; André Luz
Abstract
<p><strong>Introduction </strong></p> <p>While aortic valve replacement (AVR) is the definite treatment for aortic stenosis (AS), percutaneous balloon aortic valvuloplasty (BAV) is less expensive and easier to perform in emergent settings. BAV may be useful in selected cases as a bridge to AVR, urgent non-cardiac surgery, or palliative care.</p> <p><strong>Methods </strong></p> <p>We performed a retrospective single-centre cohort analysis of all patients submitted to BAV between 2011 and 2025. The primary endpoint was all cause mortality. Secondary endpoints included cardiovascular mortality, peri-procedural (in-hospital) complications and AVR.</p> <p><strong>Results </strong></p> <p>We included 31 consecutive BAV patients, 51.6% were female (n=16), with median age of 80 years. The presentations at admission were of acute heart failure (n=20), cardiorespiratory arrest (n=4), chest pain (n=2), and syncope (n=1). The indications for BAV were bridge to recovery (n=9), bridge to decision of further valvular intervention (n=20), and bridge to urgent non-cardiac surgery (n=2). One procedure was performed on a biologic heart valve, while the remaining were performed on native valves. Intra-operative invasive pressure gradients decreased from 55.2±20.1 mmHg to 36.6±13.0 mmHg on average. There was 1 intraprocedural death and 11 deaths during the index hospital admission. Non-fatal periprocedural complications included 6 major bleedings, 3 strokes and 2 advanced heartblocks requiring pacemaker implantation.</p> <p>Following the procedure, 5 patients were submitted to transcatheter aortic valve implantation, while 1 patient was submitted to surgical aortic valve replacement. Patients submitted to definite treatment had significantly better survival on Kaplen-Meier analysis (log rank 8.67, p=0.003). In this population, concomitant coronary artery disease (p=0.024) and malignancy (p=0.018) were the major predictors of intra-hospital mortality, with no single transthoracic echocardiography measurement showing statistical significance. </p> <p><strong>Conclusions </strong></p> <p>BAV is a technique with specific indications and should be considered in selected patients with temporary contra-indications to definitive treatment. More studies are required to definite selection criteria for palliative and immediate recovery indications. </p>
Slides
Our mission: To reduce the burden of cardiovascular disease
Visit our site